饶毅称麦角硫因是“假药” 科伦药业：不便置评他人言论

Core Viewpoint - The article discusses the controversy surrounding the drug Ergotamine, labeled as a "fake drug" by a prominent figure, which has led to significant public discourse and market reactions related to the company Kolun Pharmaceutical [1] Company Response - Kolun Pharmaceutical's securities department stated that they have not paid attention to the content of the mentioned article and prefer not to comment on others' opinions, emphasizing that investors should make their own judgments based on comprehensive information [1] Market Reaction - Following the controversial promotion of Ergotamine by Kolun Pharmaceutical's chairman, who appeared in a provocative advertisement, there was a notable surge in the stock prices of anti-aging concept stocks in the A-share market [1]